Different Exercise Training Programs in University Students with Primary Dysmenorrhea
NCT06860256, Not applicable, Not yet recruiting, Hasan Kalyoncu University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Different Exercise Training Programs in University Students with Primary Dysmenorrhea | ClinicalTrials.gov |
| NCT number | NCT06860256 | ClinicalTrials.gov |
| Status | Not yet recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 90 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Hasan Kalyoncu University | ClinicalTrials.gov |
| Conditions | Exercise, Primary Dysmenorrhea | ClinicalTrials.gov |
| Interventions | Basic Body Awareness Therapy, High Intensity Interval Training, Classic Exercise and Lifestyle Tips | ClinicalTrials.gov |
| First posted | 2025-03-06 | ClinicalTrials.gov |
| Last updated | 2025-03-06 | ClinicalTrials.gov |
Registered outcomes 13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Sociodemographic information | Two months | Sociodemographic information, physical and other medical information about the individuals' age, weight and height will be combined to report BMI in kg/m\^2 and general information about menstrual symptoms and cycles were recorded. | ClinicalTrials.gov |
| Primary | Menstrual Symptom Scale | Two months | The scale consists of 22 items and is five-point Likert type. Items 1-13 belong to "Negative effects/somatic complaints" subdimension, items 14-19 belong to "Menstrual pain symptoms" sub-dimension and items 20-22 belong to "Coping methods" subdimension. The Menstrual Symptom Scale score is calculated by averaging the total score of the items in the scale. Participants are asked to assign a number between 1 (never) and 5 (always) to the symptoms they experience related to menstruation. An increase in the mean score indicates an increase in the severity of menstrual symptoms. The scale has three subdimensions. The score obtained from the subscales is calculated by averaging the total score of the items in the subscales. An increase in the mean score for the sub-dimensions indicates an increase in the severity of menstruation. | ClinicalTrials.gov |
| Primary | The Menstrual Attitude Questionnaire | Two months | The Menstrual Attitude Questionnaire, is in Likert format and is rated on a scale from 1 to 7. The reliability coefficient of the original scale ranges from 0.95 to 0.97. In the Menstrual Attitude Questionnaire, higher average scores from the items, subgroups, or the overall scale indicate a "positive" attitude towards menstruation. | ClinicalTrials.gov |
| Primary | Evaluation of Quality of Life Short Form-12 | Two months | Evaluation of Quality of Life Short Form-12: This questionnaire was used to evaluate quality of life, which includes 12 questions about eight domains: vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning, mental health. Scoring uses the RAND system from zero to 100. The score of each domain is obtained by aggregating the question scores in every domain and dividing the resulting number by the number of questions in the same domain. A higher score indicates better quality of life.The validity and reliability of the questionnaire are approved | ClinicalTrials.gov |
| Secondary | Information About Menstruation | Two months | To determine characteristics related to menstruation,if use of medication during menstruation, including the name, dose, amount, and timing of the medication. Additionally, individuals were assessed for the presence and severity of systemic symptoms related to menstruation.The severity of these symptoms was rated as follows: 0: None, 1: Mild, 2: Moderate, 3: Severe. This evaluation was conducted on the first day of the 1st, 2nd, and 3rd menstruation cycles. | ClinicalTrials.gov |
| Secondary | Short-form McGill Pain Questionnaire | Two months | A short form of the McGill Pain Questionnaire (SF-MPQ) has been developed. The main component of the SF-MPQ consists of 15 descriptors (11 sensory; 4 affective) which are rated on an intensity scale as 0 = none, 1 = mild, 2 = moderate or 3 = severe. | ClinicalTrials.gov |
| Secondary | Pittsburgh Sleep Quality Index | Two months | The PSQI evaluates sleep quality and disturbances over a one-month period and consists of seven components: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. The score of each component ranges 0-3 and the global score is the sum of scores for these seven components with a range of 0-21. The global score of more than 5 indicates poor sleep quality. Developers have suggested that a global PSQI score \> 5 yields a diagnostic sensitivity of 89.6% and a specificity of 86.5% in distinguishing patients with sleep problems from healthy controls in their validation study. | ClinicalTrials.gov |
| Secondary | Epworth Sleepiness Scale | Two months | The Epworth Sleepiness Scale is a self-administered questionnaire with 8 questions. Respondents are asked to rate, on a 4-point scale (0-3), their usual chances of dozing off or falling asleep while engaged in eight different activities. Most people engage in those activities at least occasionally, although not necessarily every day. The ESS score (the sum of 8 item scores, 0-3) can range from 0 to 24. The higher the ESS score, the higher that person's average sleep propensity in daily life (ASP), or their 'daytime sleepiness'. The questionnaire takes no more than 2 or 3 minutes to answer. | ClinicalTrials.gov |
| Secondary | The Stroop Test Çapa Form | Two months | The Stroop Test is commonly used to evaluate executive functions such as selective attention and resistance to interference. The Stroop Test Çapa Form consists of three sub-sections: Stroop A, Stroop B, and Stroop C. The test involves two stimulus cards.On the first card, there are boxes in red, green, and blue colors. In the Stroop A section, the individual is asked to name the colors of the boxes as quickly as possible, following a left-to-right sequence.The second stimulus card contains the words "red," "green," and "blue" written in red, green, and blue ink colors, but the ink color and the word meaning are mismatched (e.g., the word "red" written in blue ink, the word "green" written in red ink).In the Stroop B section, the individual is asked to read the color names on this second card as quickly as possible.In the Stroop C section, instead of reading the words, the individual is instructed to name the ink color of the words as quickly as possible. During this task, the individu | ClinicalTrials.gov |
| Secondary | State - Trait Anxiety Inventory-STAI | Two months | The STAI state scale isscored on four levels of anxiety intensity from1 ¼ 'not at all' to 4 ¼ 'very much' and with a sumscore between 20 and 80. It is usually administeredas a self-completion questionnaire. The 20 items aredivided into two groups: ten items are formed torecord the presence of anxiety symptoms and theother ten items are scored to record the absence ofanxiety symptoms. | ClinicalTrials.gov |
| Secondary | Heart Rate Varıabılıty Measurement To Assess Stress Level Wıth Apple Watch | Two months | For Apple Watch users 18 and older, HRV is automatically recorded with Apple Watch (in most countries). However, you need to head to the Health app on iPhone to look at the data.Open the Health app on iPhone, tap the Browse tab in the bottom right corner, now choose Heart \> Heart Rate Variability,At the top, you can change the HRV data view by day. HRV is measured manually with the Apple Watch while resting and always at the same time. | ClinicalTrials.gov |
| Secondary | Perceived Stress Scale-10 | Two months | The ASQ-10 scale a total of 10 items, the PSS-10 was created to measure the level of stress perceived by the individual in situations encountered in life. On a five-point Likert-type scale, participants rate each item from "Never (0)" to "Very often (4)". Items with positive statements (items 4,5,7,8) are reverse scored. A high score on the ASQ-10 scale, whose total score ranges between 0 and 40, indicates that the person's stress perception is high. The ASQ-10 scale was adapted into Turkish by Eskin et al. | ClinicalTrials.gov |
| Secondary | Academic Stress Scale | Two months | The 27-item scale aims to measure the general academic stress levels of university students. It consists of four sub-dimensions: difficulties in the classroom, difficulties outside the classroom, difficulties in interacting with the university and difficulties in managing different areas. The first six items of the scale belong to the difficulties in the classroom sub-dimension. The next eight items of the scale (items 7-14) belong to the difficulties outside the classroom sub-dimension. The other eight items of the scale (items 15-22) belong to the difficulties in interacting with the university sub-dimension. The last five items of the scale (items 23-27) belong to the difficulties in managing different domains sub-dimension. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 1
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)